About UPM Biochemicals
UPM Biochemicals is a company based in Helsinki (Finland) founded in 1996. UPM Biochemicals has completed 1 acquisition, including SunCoal. UPM Biochemicals offers products and services including Bio-Monoethylene Glycol, Bio-Monopropylene Glycol, Renewable Functional Fillers, Lignin Solutions, and Industrial Sugar. UPM Biochemicals operates in a competitive market with competitors including Evonik, Solugen, LanzaTech, Manus Bio and Calyxia, among others.
- Headquarter Helsinki, Finland
-
Sectors
Chemicals & Materials
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Upm-Kymmene Oyj
-
Annual Revenue
$2.08 B (USD)26as on Dec 31, 2022
-
Net Profit
$1.64 B (USD)19as on Dec 31, 2022
-
EBITDA
$2.05 B (USD)26as on Dec 31, 2022
-
Latest Funding Round
$14.46 M (USD), Grant
Dec 15, 2022
- Investors
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of UPM Biochemicals
UPM Biochemicals offers a comprehensive portfolio of products and services, including Bio-Monoethylene Glycol, Bio-Monopropylene Glycol, Renewable Functional Fillers, Lignin Solutions, and Industrial Sugar.
Ethylene glycol derived from wood for industrial applications.
Propylene glycol from sustainable sources for various uses.
Fillers made from renewable sources to enhance product performance.
Lignin-based products for integration into production processes.
Sugar derived from wood for industrial and biochemical applications.
Funding Insights of UPM Biochemicals
Investors in UPM Biochemicals
UPM Biochemicals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for UPM Biochemicals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by UPM Biochemicals
UPM Biochemicals has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include SunCoal.
Investment portfolio details for UPM Biochemicals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Development and validation services for pharmaceuticals are provided by SunCoal.
|
Locked | Locked | 2007 | Locked |
Complete acquisition details for UPM Biochemicals
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - UPM Biochemicals
Detailed financials for UPM Biochemicals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Upm Biochemicals Comparisons
Peer comparison for UPM Biochemicals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of UPM Biochemicals
UPM Biochemicals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evonik, Solugen, LanzaTech, Manus Bio and Calyxia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Green specialty chemicals are developed and supplied for multiple industries.
|
|
| Locked | Locked | Locked |
Sustainable bio-based chemicals are manufactured using a proprietary platform.
|
|
| Locked | Locked | Locked |
Waste carbon is treated via a bio-processing platform.
|
|
| Locked | Locked | Locked |
Phytochemicals are developed using microbial fermentation processes.
|
|
| Locked | Locked | Locked |
Green chemicals are developed using microcapsule technology for sustainability.
|
|
| Locked | Locked | Locked |
Diversified green chemicals are manufactured from bio-renewable resources.
|
Detailed competitors of UPM Biochemicals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Upm Biochemicals
Complete news archive for UPM Biochemicals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about UPM Biochemicals
UPM Biochemicals was founded in 1996 and raised its 1st funding round 26 years after it was founded.
UPM Biochemicals is headquartered in Helsinki, Finland.
Jussi Pesonen is the current CEO of UPM Biochemicals.
Annual revenue of UPM Biochemicals is $2.08B as on Dec 31, 2022.
Wood-based biochemical manufacturer. Its applications are in replacing fossil-raw materials, forestry, climate neutral feedstock, and glycol production.
UPM Biochemicals offers Bio-Monoethylene Glycol, Bio-Monopropylene Glycol, Renewable Functional Fillers, Lignin Solutions, and Industrial Sugar.
UPM Biochemicals has made 1 acquisition, including SunCoal.
UPM Biochemicals has 1 investor. Key investors include European Union.